For help on how to get the results you want, see our search tips.
5 results
Medicine
Maximum residue limits Remove Maximum residue limits filter
Withdrawn applications Remove Withdrawn applications filter
Summaries of opinion Remove Summaries of opinion filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Medicine type
Exceptional circumstances Remove Exceptional circumstances filter
Accelerated assessment Remove Accelerated assessment filter
Conditional approval Remove Conditional approval filter
Opinion status
Positive Remove Positive filter
-
List item
Summary of opinion: Rybrevant
amivantamab, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Lenvima
lenvatinib, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Kisplyx
lenvatinib, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Epclusa (new)
sofosbuvir, velpatasvir, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Kalydeco (new)
ivacaftor, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021